Physician profile
Nadia Dussard Wright
NPI 1790307155
$704.94
in general payments reported to CMS, 2019-2025
17 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.14 · 2022: $135 · 2023: $245 · 2024: $134 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $99.49 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $92.34 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $70.34 | 2021-2023 | |
| Glaxosmithkline, LLC. | $67.43 | 2023-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $49.03 | 2021-2022 | |
| Amgen INC. | $48.09 | 2024-2025 | Repatha, Otezla, Repatha |
| Almatica Pharma LLC | $40.44 | 2022-2023 | Loreev Xr, Gralise |
| Novartis Pharmaceuticals Corporation | $40.08 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $39.45 | 2021-2022 | |
| Exact Sciences Corporation | $33.85 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $28.15 | 2022-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $21.87 | 2023 | |
| Seqirus USA INC | $19.00 | 2024 | Flucelvax, Fluad |
| Genentech USA, INC. | $14.92 | 2022 | |
| Althera Pharmaceuticals LLC | $14.25 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.17 | 2025 | Camzyos |
| Athena Bioscience, LLC | $12.04 | 2023 | Nexiclon Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Dussard Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.